PROF
PROF
NASDAQ · Health Care

Profound Medical Corp

$6.48
+0.53 (+8.91%)
Financial Highlights (FY 2025)
Revenue
122.55M
Net Income
12.18M
Gross Margin
58.7%
Profit Margin
9.9%
Rev Growth
-0.5%
D/E Ratio
0.68
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 58.7% 58.7% 58.7%
Operating Margin 12.9% 13.1% 12.1%
Profit Margin 9.9% 10.1% 13.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 122.55M 110.97M 130.03M
Gross Profit 71.94M 65.14M 76.33M
Operating Income 15.84M 14.49M 15.72M
Net Income 12.18M 11.22M 17.35M
Gross Margin 58.7% 58.7% 58.7%
Operating Margin 12.9% 13.1% 12.1%
Profit Margin 9.9% 10.1% 13.3%
Rev Growth -0.5% +15.1% +0.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 138.65M 159.28M 166.07M
Total Equity 203.98M 201.01M 174.26M
D/E Ratio 0.68 0.79 0.95
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 20.91M 16.88M 21.68M
Free Cash Flow 14.20M 17.89M 15.74M